Clinical Trials Directory

Trials / Terminated

TerminatedNCT00748228

Dopamine in Orthostatic Tolerance

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

One goal of this study is to determine whether people with different amounts of dopamine-beta-hydroxylase (DBH) have different responses to events that affect blood pressure and heart rate. We will also study whether increasing dietary salt improves symptoms during upright posture. Finally, we will examine whether the dietary sodium level influences serum DBH activity and whether DBH level influences the response to sodium. DBH levels and the function of the sympathetic or involuntary nervous system will be assessed in normal volunteers and in patients with postural tachycardia syndrome (POTS).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdietary sodium10 mEq/day
DIETARY_SUPPLEMENTdietary sodium300 mEq/day
DIETARY_SUPPLEMENTdietary sodium150 mEq/day dietary sodium

Timeline

Start date
2004-11-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2008-09-08
Last updated
2015-06-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00748228. Inclusion in this directory is not an endorsement.